Shoucheng Ning

2.0k total citations
41 papers, 1.5k citations indexed

About

Shoucheng Ning is a scholar working on Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shoucheng Ning has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shoucheng Ning's work include Cancer, Hypoxia, and Metabolism (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Shoucheng Ning is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Shoucheng Ning collaborates with scholars based in United States, France and India. Shoucheng Ning's co-authors include Susan J. Knox, Bryan Oronsky, Donna M. Peehl, Jan Scicinski, Chaoxiang Shui, Mark D. Bednarski, Kirk Trisler, Barry W. Wessels, Julie M. Cherrington and Douglas Laird and has published in prestigious journals such as Journal of Clinical Investigation, Cancer and Cancer Research.

In The Last Decade

Shoucheng Ning

41 papers receiving 1.5k citations

Peers

Shoucheng Ning
Marie‐France Penet United States
Di Jia China
Branislava Janic United States
R K Jain United States
Weiye Deng United States
Sang‐Yeob Kim South Korea
Marie‐France Penet United States
Shoucheng Ning
Citations per year, relative to Shoucheng Ning Shoucheng Ning (= 1×) peers Marie‐France Penet

Countries citing papers authored by Shoucheng Ning

Since Specialization
Citations

This map shows the geographic impact of Shoucheng Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoucheng Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoucheng Ning more than expected).

Fields of papers citing papers by Shoucheng Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoucheng Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoucheng Ning. The network helps show where Shoucheng Ning may publish in the future.

Co-authorship network of co-authors of Shoucheng Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Shoucheng Ning. A scholar is included among the top collaborators of Shoucheng Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoucheng Ning. Shoucheng Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jing, L. Bekale, Kelly Khomtchouk, et al.. (2020). Locally administered heparin-binding epidermal growth factor-like growth factor reduces radiation-induced oral mucositis in mice. Scientific Reports. 10(1). 17327–17327. 6 indexed citations
2.
Oronsky, Bryan, et al.. (2018). A note on improved statistical approaches to account for pseudoprogression. Cancer Chemotherapy and Pharmacology. 81(3). 621–626. 4 indexed citations
3.
Zhao, Hongjuan, Shoucheng Ning, Rosalie Nolley, et al.. (2017). The immunomodulatory anticancer agent, RRx-001, induces an interferon response through epigenetic induction of viral mimicry. Clinical Epigenetics. 9(1). 4–4. 36 indexed citations
4.
Oronsky, Bryan, Jan Scicinski, Shoucheng Ning, et al.. (2016). RRx-001, A novel dinitroazetidine radiosensitizer. Investigational New Drugs. 34(3). 371–377. 40 indexed citations
5.
Scicinski, Jan, Bryan Oronsky, Shoucheng Ning, et al.. (2015). NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001. Redox Biology. 6. 1–8. 90 indexed citations
6.
Reid, Tony, Bryan Oronsky, Jan Scicinski, et al.. (2015). Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study. The Lancet Oncology. 16(9). 1133–1142. 76 indexed citations
7.
Ning, Shoucheng, Mark D. Bednarski, Bryan Oronsky, Jan Scicinski, & Susan J. Knox. (2014). Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy. Biochemical and Biophysical Research Communications. 447(3). 537–542. 30 indexed citations
8.
Ning, Shoucheng, Grant R. Budas, Eric N. Churchill, et al.. (2012). Mitigation of Radiation-Induced Dermatitis by Activation of Aldehyde Dehydrogenase 2 Using Topical Alda-1 in Mice1. Radiation Research. 178(1). 69–74. 27 indexed citations
9.
Ning, Shoucheng, Susan J. Knox, Griffith R. Harsh, Michael D. Culler, & Laurence Katznelson. (2009). Lanreotide promotes apoptosis and is not radioprotective in GH3 cells. Endocrine Related Cancer. 16(3). 1045–1055. 9 indexed citations
10.
Ning, Shoucheng, Zhijian J. Chen, Amie J. Dirks, et al.. (2007). Targeting Integrins and PI3K/Akt-Mediated Signal Transduction Pathways Enhances Radiation-Induced Anti-angiogenesis. Radiation Research. 168(1). 125–133. 19 indexed citations
11.
Ning, Shoucheng & Susan J. Knox. (2006). Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma. International Journal of Radiation Oncology*Biology*Physics. 65(2). 493–498. 25 indexed citations
12.
Li, Lingyun, Charles Wartchow, S. Narasimhan Danthi, et al.. (2004). A novel antiangiogenesis therapy using an integrin antagonist or anti–Flk-1 antibody coated 90Y-labeled nanoparticles. International Journal of Radiation Oncology*Biology*Physics. 58(4). 1215–1227. 102 indexed citations
13.
Maxim, Peter G., Jeffrey J. L. Carson, Shoucheng Ning, et al.. (2004). Enhanced Effectiveness of Radiochemotherapy with Tirapazamine by Local Application of Electric Pulses to Tumors. Radiation Research. 162(2). 185–193. 10 indexed citations
14.
Ning, Shoucheng & Susan J. Knox. (2004). Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. International Journal of Radiation Oncology*Biology*Physics. 60(1). 197–203. 35 indexed citations
15.
Ning, Shoucheng, Douglas Laird, Julie M. Cherrington, & Susan J. Knox. (2002). The Antiangiogenic Agents SU5416 and SU6668 Increase the Antitumor Effects of Fractionated Irradiation. Radiation Research. 157(1). 45–51. 97 indexed citations
16.
Ning, Shoucheng, Ning Yu, Dennis Brown, Sarathchandra Kanekal, & Susan J. Knox. (1999). Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system. Radiotherapy and Oncology. 50(2). 215–223. 45 indexed citations
17.
Ning, Shoucheng, et al.. (1998). Effects of Keratinocyte Growth Factor on the Proliferation and Radiation Survival of Human Squamous Cell Carcinoma Cell Lines In Vitro and In Vivo. International Journal of Radiation Oncology*Biology*Physics. 40(1). 177–187. 70 indexed citations
18.
Ning, Shoucheng, Kirk Trisler, Barry W. Wessels, & Susan J. Knox. (1997). Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in Vitro and in Vivo in human renal cell carcinoma xenografts. Cancer. 80(S12). 2519–2528. 8 indexed citations
19.
Ning, Shoucheng, Kirk Trisler, Dennis Brown, et al.. (1996). Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-release gel. Radiotherapy and Oncology. 39(2). 179–189. 8 indexed citations
20.
Ning, Shoucheng, et al.. (1994). Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. International Journal of Radiation Oncology*Biology*Physics. 29(4). 827–834. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026